Authors
Denise Myshko is the editor of Formulary Watch.
Ajai Chari, MD, is an expert in hematologic oncology who cares for patients at University of California San Francisco Health.
Mark F. Pyfer, MD, is a board-certified ophthalmic surgeon at Northern Ophthalmic Associates in Jenkintown, Pennsylvania. He is also on the volunteer teaching faculty and medical staff at Wills Eye Hospital and Thomas Jefferson University. This commentary represents his own personal opinion.
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
3
Addressing Mental Health Challenges Among Black and Latino Boys
4
Epstein-Barr Virus Link to MS Spurs New Vaccine and T-Cell Trials
5


